Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Validated sandwich ELISA for the quantification of von Willebrand factor in rabbit plasma.

Smith BW, Strakova J, King JL, Erdman JW, O'Brien WD.

Biomark Insights. 2010 Nov 28;5:119-27. doi: 10.4137/BMI.S6051.

2.

An enzyme-linked immunosorbent assay (ELISA) for von Willebrand factor antigen (vWf-Ag) in canine plasma.

Slappendel RJ, Frielink RA, Mol JA, Noordzij A, Hamer R.

Vet Immunol Immunopathol. 1992 Jun;33(1-2):145-54.

PMID:
1632075
3.

A sensitive immunoassay for von Willebrand factor.

Benson RE, Catalfamo JL, Brooks M, Dodds WJ.

J Immunoassay. 1991;12(3):371-90.

PMID:
1939665
5.

An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma.

Vinholt PJ, Overgaard M, Diederichsen AC, Mickley H, Poulsen TS, Sand NP, Nybo M, Rasmussen LM.

Thromb Res. 2013 May;131(5):396-400. doi: 10.1016/j.thromres.2013.03.001. Epub 2013 Mar 23.

PMID:
23531238
6.

A multispecies enzyme-linked immunosorbent assay for von Willebrand's factor.

Benson RE, Catalfamo JL, Dodds WJ.

J Lab Clin Med. 1992 Apr;119(4):420-7.

PMID:
1583394
8.

The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications.

Casonato A, Pontara E, Zerbinati P, Zucchetto A, Girolami A.

Am J Clin Pathol. 1998 Mar;109(3):347-52.

PMID:
9495210
9.

[Platelet activation and endothelial factors in standard exercise test before and after menopause].

Krzysiek J, Milewicz T, Dybkowski R, Janczak-Saif A, Dembińska-Kieć A, Anna AZ, Guevara I, Sztefko K, Radowicki S, Dubiel JS, Klimek R.

Przegl Lek. 2001;58(5):419-25. Polish.

PMID:
11603175
10.

Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.

Hillarp A, Friedman KD, Adcock-Funk D, Tiefenbacher S, Nichols WL, Chen D, Stadler M, Schwartz BA.

Haemophilia. 2015 Nov;21(6):837-45. doi: 10.1111/hae.12703. Epub 2015 Jul 14.

PMID:
26172561
11.

Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.

Zhukov O, Popov J, Ramos R, Vause C, Ruden S, Sferruzza A, Dlott J, Sahud M.

Haemophilia. 2009 May;15(3):788-96. doi: 10.1111/j.1365-2516.2009.01995.x. Epub 2009 Feb 27.

PMID:
19298374
12.

A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.

Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H.

Semin Thromb Hemost. 2002 Apr;28(2):161-6.

PMID:
11992239
13.

Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA.

Vanhoorelbeke K, Pareyn I, Schlammadinger A, Vauterin S, Hoylaerts MF, Arnout J, Deckmyn H.

Thromb Haemost. 2005 Jan;93(1):165-71.

PMID:
15630508
15.
16.
19.

Application of an enzyme-linked immunosorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives.

Silveira AM, Yamamoto T, Adamson L, Hessel B, Blombäck B.

Thromb Res. 1986 Jul 1;43(1):91-102.

PMID:
2425450
20.

Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.

Popov J, Zhukov O, Ruden S, Zeschmann T, Sferruzza A, Sahud M.

Clin Chem. 2006 Oct;52(10):1965-7. Epub 2006 Aug 3.

Supplemental Content

Support Center